Loading…

Type 1 diabetes and viral infections: What is the relationship?

•Type 1 diabetes (TID) is an autoimmune disease.•Viruses play a major role in some cases of T1D.•Viral damage associated with T1D can be direct or immune-mediated.•Increased knowledge of the link between viral infections and T1D seems essential. Type 1 diabetes (T1D) is the most common chronic metab...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical virology 2017-11, Vol.96, p.26-31
Main Authors: Principi, Nicola, Berioli, Maria Giulia, Bianchini, Sonia, Esposito, Susanna
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Type 1 diabetes (TID) is an autoimmune disease.•Viruses play a major role in some cases of T1D.•Viral damage associated with T1D can be direct or immune-mediated.•Increased knowledge of the link between viral infections and T1D seems essential. Type 1 diabetes (T1D) is the most common chronic metabolic disorder in children. Epigenetic and environmental factors capable of altering the penetrance of major susceptibility genes or capable of increasing the penetrance of low-risk genes are currently thought to play a role in triggering autoimmunity and T1D development. This paper discusses the current knowledge of the role of viruses in T1D. Most studies that have evaluated the potential association between viral infections and T1D have indicated that it is highly likely that some of these infectious agents play a role in T1D development. However, most T1D cases are immune-mediated, and it is supposed that the initial viral infection is capable of creating, in genetically predisposed subjects, a particular condition in which chronic local inflammation occurs through the persistence of the infecting virus in pancreatic tissue and the activation of autoimmunity by means of molecular mimicry, bystander activation, or both. Theoretically, this knowledge could lead to possible prophylaxis and therapy for T1D. Further studies devoted to evaluating which infectious agents are linked to T1D and which immune mechanisms induce or protect against the disease are needed before adequate prophylactic and therapeutic measures can be developed.
ISSN:1386-6532
1873-5967
DOI:10.1016/j.jcv.2017.09.003